The FDA permitted REZDIFFRA according to evidence of efficacy from a clinical trial, Demo 1, of 888 clients who had a liver biopsy displaying inflammation as a consequence of NASH with average or State-of-the-art liver scarring, although not with cirrhosis on the liver.It happens if the Fats from the liver becomes harmful to you, harmful liver cell